Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome

Epilepsia

Volumn 41, Issue 1, 2000, Pages 19-23

  Musumeci, Sebastiano A ^a   Bosco, Paolo ^a   Calabrese, Giuseppe ^a   Bakker, Cathy ^c   De Sarro, Giovanni B ^b   Elia, Maurizio ^a   Ferri, Raffaele ^a   Oostra, Ben A ^c  

^a OASI RESEARCH INSTITUTE IRCCS   (Italy)

^b UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Audiogenic seizures; Epilepsy; FMR1; Fragile X syndrome; Transgenic mice

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDIOGENIC SEIZURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FRAGILE X SYNDROME; HETEROZYGOSITY; HOMOZYGOSITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE SUSCEPTIBILITY;

EID: 0033987591     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.2000.tb01499.x     Document Type: Article

References (32)

1. Hagerman R. Clinical and diagnostic aspects of fragile X syndrome. In: Wells RD, Warren ST, eds. Genetic instabilities and hereditary neurological diseases. New York: Academic Press, 1998:15-23.
2. Turner G, Webb T, Wake S, Robinson H. The prevalence of the fragile X syndrome. Am J Med Genet 1996;64:196-7.
3. Kooij RF, Oostra BA, Willems PJ. The fragile X syndrome and other fragile site disorders. In: Oostra BA, ed. Trinucleotide diseases and instability. Heidelberg: Springer, 1998:1-46.
4. Fu YH, Kuhl DP, Pizzuti A, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991;67:1047-58.
5. Pieretti M, Zhang FP, Fu YH, et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991;66:817-22.
6. Verheij C, Bakker CE, de Graaff E, et al. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature 1993;363:722-4.
7. Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 1993;4:335-40.
8. Deelen W, Bakker C, Halley D, Oostra BA. Conservation of CGG region in FMR1 gene in mammals. Am J Med Genet 1994;51: 513-6.
9. Ashley CT, Sutcliffe JS, Kunst CB, et al. Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nat Genet 1993;4:244-51.
10. Comery TA, Harris JB, Willems PJ, et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci U S A 1997;94:5401-4.
11. Bakker CE, Verheij C, Willemsen R, et al. Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 1994;78:23-33.
12. Kooy RF, Dhooge R, Reyniers E, et al. Transgenic mouse model for the fragile X syndrome. Am J Med Genet 1996;64:241-5.
13. Musumeci SA, Hagerman RJ, Ferri R, et al. Epilepsy, and EEG findings in males with fragile X syndrome. Epilepsia 1999;40: 1092-9.
14. Musumeci SA, Colognola RM, Ferri R, et al. Fragile-X syndrome: a particular epileptogenic EEG pattern. Epilepsia 1988;29:41-7.
15. Ferri R, Musumeci SA, Elia M, Del Gracco S, Scuderi C, Bergonzi P. Bit-mapped somatosensory evoked potentials in the fragile X syndrome. Neurophysiol Clin 1994;24:413-26.
16. Hall CS. Genetic differences in fatal audiogenic seizures. J Hered 1947;38:3-6.
17. Engstrom FL, Woodbury DM. Seizure susceptibility in DBA and C57 mice: the effects of various convulsants. Epilepsia 1988; 29:389-95.
18. Wang H, Burdette LJ, Frankel WN, Masukawa LM. Paroxysmal discharges in the EL mouse, a genetic model of epilepsy. Brain Res 1997;760:266-71.
19. Neumann PE, Seyfried TN. Mapping of two genes that influence susceptibility to audiogenic seizures in crosses of C57BL/6J and DBA/2J mice. Behav Genet 1990;20:307-23.
20. Rise ML, Frankel WN, Coffin JM, Seyfried TN. Genes for epilepsy mapped in the mouse. Science 1991;253:669-73.
21. Brennan TJ, Seeley WW, Kilgard M, Schreiner CE, Tecott LH. Sound-induced seizures in serotonin 5-HT2C receptor mutant mice. Nat Genet 1997;16:387-90.
22. Goelz MF, Mahler J, Harry J, et al. Neuropathologic findings associated with seizures in FVB mice. Lab Anim Sci 1998;48:34-7.
23. Debai HB, Donat J, Shokeir MH, Munoz DG. Amyotrophic lateral sclerosis in a patient with fragile X syndrome. Neurology 1990;40:378-80.
24. Rudelli RD, Brown WT, Wisniewski HM. Adult fragile X syndrome. Acta Neuropathol (Berl) 1985;67:289-95.
25. Hinton VJ, Brown WT, Wisniewski K, Rudelli RD. Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet 1991;41:289-94.
26. Holmes GL. Pathogenesis of epilepsy: the role of excitatory amino acids. Cleve Clin J Med 1995;62:240-7.
27. Reiss AL, Lee J, Freund L. Neuroanatomy of fragile X syndrome: the temporal lobe. Neurology 1994;44:1317-24.
28. Abitbol M, Menini C, Delezoide AL, Rhyner T, Vekemans M, Mallet J. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat Genet 1993;4:147-53.
29. Eberhart DE, Malter HE, Feng Y, Warren ST. The fragile X mental retardation protein is a ribosonucleoprotein containing both nuclear localization and nuclear export signals. Hum Mol Genet 1996;5:1083-91.
30. Tamanin F, Bontekoe C, Bakker CE, et al. Different targets for the fragile X related proteins revealed by their distinct nuclear localizations. Hum Mol Genet 1999 (in press).
31. Siomi MC, Zhang Y, Siomi H, Dreyfuss G. Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them. Mol Cell Biol 1996;16:3825-32.
32. Feng Y, Gutekunst CA, Eberhart DE, Yi H, Warren ST, Hersch SM. Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 1997;17:1539-47.